Delivery Order SPE2DB20D2104-SPE2DB25FMXZW
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,786.70 on May 8, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order is set to be completed by May 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The Defense Logistics Agency awarded a delivery order valued at $3,135.68 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (1,000 count) under a firm fixed-price contract valued at $1,430.00. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 1,000 tablets of Synthroid 25 micrograms, with a ceiling value of $1,539.70. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 micrograms on August 15, 2025, with a ceiling value of $1,430.59 and an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,091.35 firm fixed-price delivery order is for the supply of Synthroid 100 mcg tablets in 1,000-count containers. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,480 units of Synthroid 50mcg medication. The contract has a potential value of $5,024.16 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. This delivery order is part of a larger...
- This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is for the supply of 4,565,951,410 Synthroid 125mcg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $3,560.68 and a completion date of September 26, 2024. This delivery order does not utilize a set-aside....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms at a ceiling value of $2,134.25. This is a firm fixed-price delivery order with no set-aside designation, completed by July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $37,492.95 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 88 micrograms, a thyroid hormone replacement medication. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXZWDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units, with a ceiling value of $2,012.16. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive set-aside award. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, supporting federal pharmaceutical procurement needs. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates consistent capability in fulfilling competitively awarded delivery orders across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard through the flexible DLA contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/15/25 |